MICROBIAL ETIOLOGIES, CLINICAL AND BIOCHEMICAL CHARACTERISTICS OF ACUTE RESPIRATORY DISTRESS SYNDROME

Trọng Nam Đỗ , Tuấn Đạt Nguyễn , Thị Thuỳ Dung Nguyễn

Main Article Content

Abstract

Objective: To assess certain factors related to mortality in patients with progressive acute respiratory distress syndrome (ARDS) due to pneumonia in the intensive care unit (ICU). Subjects and Methods: A cross-sectional descriptive study was conducted on 49 patients diagnosed with progressive ARDS due to pneumonia at the Emergency Center A9 - Bach Mai Hospital from August 2018 to August 2022. Results: Out of a total of 49 patients, 67.4% (33/49) were male with a mean age of 62.0 (Q1 - Q2: 48.5 - 72.5) years. Upon admission, the majority of patients exhibited moderate (40.8%; 20/49) to severe (46.9%; 23/49) hypoxemia according to the Berlin criteria, and respiratory viruses (36.7%; 18/49) were the most common cause of pneumonia, with H1N1 virus (29.2%; 14/48) being the highest proportion. Conclusion: Blood tests and biochemical tests in ARDS pneumonia to reflect organ damage and systemic inflammatory response are non-specific in diagnosis. Arterial blood gas analysis is an important test in the diagnosis and monitoring of ARDS patients

Article Details

References

Peter J.V., John P., Graham P.L. et al (2008). Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: meta-analysis. BMJ, 336(7651), 1006–1009.
2. Bellani G., Laffey J.G., Pham T. et al (2016). Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries. JAMA, 315(8), 788–800.
3. Chinh L.Q., Manabe T., Son D.N. et al (2019). Clinical epidemiology and mortality on patients with acute respiratory distress syndrome (ARDS) in Vietnam. PLoS One, 14(8), e0221114.
4. Zilberberg M.D. và Epstein S.K. (1998). Acute lung injury in the medical ICU: comorbid conditions, age, etiology, and hospital outcome. Am J Respir Crit Care Med, 157(4 Pt 1), 1159–1164.
5. Jennings LC, Anderson TP, Beynon KA, et al. Incidence and characteristics of viral community-acquired pneumonia in adults. Thorax. 2008;63 (1):42-48.
6. Li SH, Hsieh MJ, Lin SW, et al. Outcomes of severe H1N1 pneumoniae: A retrospective study at intensive care units. J Formos Med Assoc. 2020;119(1 Pt 1):26-33.
7. Metlay JP, Waterer GW, Long AC, et al. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019;200(7):e45-e67.
8. ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, et al. Acute respiratory distress syndrome: The Berlin Definition. JAMA.2012; 307(23):2526-2533.
9. Pachon J., Prados M.D., Capote F. et al. (1990). Severe community-acquired pneumonia. Etiology, prognosis, and treatment. Am Rev Respir Dis, 142(2), 369–373.
10. Torres A., Serra-Batlles J., Ferrer A. et al. (1991). Severe community-acquired pneumonia. Epidemiology and prognostic factors. Am Rev Respir Dis, 144(2), 312–318.